Vivani Medical, Inc. Revenue from Contract with Customer, Including Assessed Tax
Vivani Medical, Inc. (VANI) reported Revenue from Contract with Customer, Including Assessed Tax of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-03-26
- Vivani Medical, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $0.00.
- Vivani Medical, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-03-31 was $0.00.
- Vivani Medical, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2024-12-31 was $0.00.
- Vivani Medical, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2024-09-30 was $0.00.
- Vivani Medical, Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $0.00.
- Vivani Medical, Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $0.00.
- Vivani Medical, Inc. revenue from contract with customer, including assessed tax for fiscal 2019 was $3.38M.
- Vivani Medical, Inc. revenue from contract with customer, including assessed tax for fiscal 2017 was $7.96M, a 99.85% increase from fiscal 2016.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month | Revenue from Contract with Customer, Including Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $0.00 derived: sum of 4 quarters · filed 2025-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $0.00 derived: sum of 3 quarters · filed 2025-05-13 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | |||
| 2019-12-31 | $497.00K 10-K · filed 2021-03-16 | $969.00K derived: sum of 2 quarters · filed 2021-03-16 | $2.25M derived: sum of 3 quarters · filed 2021-03-16 | $3.38M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $472.00K 10-K · filed 2021-03-16 | $1.75M derived: sum of 2 quarters · filed 2021-03-16 | $2.88M 10-Q · filed 2020-11-12 | $4.65M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-06-30 | $1.28M 10-K · filed 2021-03-16 | $2.41M 10-Q · filed 2020-08-13 | $4.18M derived: sum of 3 quarters · filed 2021-03-16 | $6.42M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-03-31 | $1.13M 10-K · filed 2021-03-16 | $2.90M derived: sum of 2 quarters · filed 2021-03-16 | $5.14M derived: sum of 3 quarters · filed 2021-03-16 | $7.05M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-12-31 | $1.77M 10-K · filed 2020-03-19 | $4.01M derived: sum of 2 quarters · filed 2020-03-19 | $5.92M derived: sum of 3 quarters · filed 2020-03-19 | $6.90M 10-Q · filed 2020-11-12 | $6.90M 10-K · filed 2019-03-19 |
| 2018-09-30 | $2.25M 10-K · filed 2020-03-19 | $4.15M derived: sum of 2 quarters · filed 2020-03-19 | $5.13M 10-Q · filed 2019-11-14 | $8.24M derived: sum of 4 quarters · filed 2020-03-19 | |
| 2018-06-30 | $1.91M 10-K · filed 2020-03-19 | $2.88M 10-Q · filed 2019-08-06 | $5.99M derived: sum of 3 quarters · filed 2020-03-19 | $7.60M derived: sum of 4 quarters · filed 2020-03-19 | |
| 2018-03-31 | $976.00K 10-K · filed 2020-03-19 | $4.08M derived: sum of 2 quarters · filed 2020-03-19 | $5.70M derived: sum of 3 quarters · filed 2020-03-19 | $7.93M derived: sum of 4 quarters · filed 2020-03-19 | |
| 2017-12-31 | $3.11M 10-K · filed 2019-03-19 | $4.72M derived: sum of 2 quarters · filed 2019-03-19 | $6.96M derived: sum of 3 quarters · filed 2019-03-19 | $7.96M 10-K · filed 2019-03-19 | |
| 2017-09-30 | $1.61M 10-K · filed 2019-03-19 | $3.85M derived: sum of 2 quarters · filed 2019-03-19 | $4.86M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $2.24M 10-K · filed 2019-03-19 | $3.25M 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | $1.01M 10-K · filed 2019-03-19 | ||||
| 2016-12-31 | $3.98M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |